Moody Aldrich Partners’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,465
Closed -$1.3M 218
2024
Q2
$1.3M Sell
24,465
-31,270
-56% -$1.66M 0.25% 111
2024
Q1
$4.57M Buy
+55,735
New +$4.57M 0.78% 58
2023
Q3
Sell
-194,470
Closed -$3.15M 215
2023
Q2
$3.15M Sell
194,470
-9,356
-5% -$152K 0.61% 68
2023
Q1
$3.39M Buy
203,826
+907
+0.4% +$15.1K 0.69% 61
2022
Q4
$1.91M Buy
+202,919
New +$1.91M 0.39% 86